Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway

Vaccine

Volumn 30, Issue 27, 2012, Pages 4106-4112

  Su, Fei ^a   Yuan, Lin ^b   Zhang, Lijia ^a   Hu, Songhua ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b Institute of Microbiology   (China)

Author keywords

Adjuvant; Ginseng; Ginsenoside; NF B; Toll like receptor

Indexed keywords

GAMMA INTERFERON; GINSENOSIDE RE; GINSENOSIDE RG 1; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; OVALBUMIN; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG ISOLATION; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CYTOKINES; GINSENOSIDES; MICE; MICE, INBRED C3H; OVALBUMIN; PANAX; PHOSPHORYLATION; PLANT EXTRACTS; PLANT ROOTS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS;

EID: 84861479561     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.03.052     Document Type: Article

References (36)

1. Xie J.T., McHendale S., Yuan C.S. Ginseng and diabetes. The American Journal of Chinese Medicine 2005, 33(3):397-404.
2. Chen C.F., Chiou W.F., Zhang J.T. Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium. Acta Pharmacologica Sinica 2008, 29(9):1103-1108.
3. Ding L.W. Investigation of ginseng markets. Modern Chinese Medicine 2010, 12(11):44-48.
4. Jia L., Zhao Y.Q. Current evaluation of the millennium phytomedicine-ginseng (I): etymology, pharmacognosy, phytochemistry, market and regulations. Current Medicinal Chemistry 2009, 16(19):2475-2484.
5. Cheng Y., Shen L.H., Zhang J.T. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacologica Sinica 2005, 26(2):143-149.
6. Rivera E., Hu S., Concha C. Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants. Vaccine 2003, 21(11-12):1149-1157.
7. Kong X.F., Hu Y.L., Rui R., Wang D.Y., Li X.R. Effects of Chinese herbal medicinal ingredients on peripheral lymphocyte proliferation and serum antibody titer after vaccination in chicken. International Immunopharmacology 2004, 4(7):975-982.
8. Qu D.F., Yu H.J., Liu Z., Zhang D.F., Zhou Q.J., Zhang H.L., et al. Ginsenoside Rg1 enhances immune response induced by recombinant Toxoplasma gondii SAG1 antigen. Veterinary Parasitology 2011, 179(1-3):28-34.
9. Rivera E., Daggfeldt A., Hu S. Ginseng extract in aluminium hydroxide adjuvanted vaccines improves the antibody response of pigs to porcine parvovirus and Erysipelothrix rhusiopathiae. Veterinary Immunology and Immunopathology 2003, 91(1):19-27.
10. Rivera E., Ekholm Pettersson F., Inganas M., Paulie S., Gronvik K.O. The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine 2005, 23(46-47):5411-5419.
11. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annual Review Immunology 2003, 21:335-376.
12. Mishra B.B., Gundra U.M., Teale J.M. Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis. Journal of Neuroinflammation 2008, 5:53.
13. Martinez J., Huang X.P., Yang Y.P. Toll-like receptor 8-mediated activation of murine plasmacytoid dendritic cells by vaccinia viral DNA. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(14):6442-6447.
14. Yarovinsky F., Zhang D.K., Andersen J.F., Bannenberg G.L., Serhan C.N., Hayden M.S., et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005, 308(5728):1626-1629.
15. Shi Z.C., Cai Z.Y., Wen S., Chen C.Y., Gendron C., Sanchez A., et al. Transcriptional regulation of the novel Toll-like receptor Tlr13. Journal of Biology and Chemistry 2009, 284(31):20540-20547.
16. Guan Y., Ranoa D.R., Jiang S., Mutha S.K., Li X.Y., Baudry J., et al. Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling. Journal of Immunology 2010, 184(9):5094-5103.
17. Takeda K., Akira S. Regulation of innate immune responses by Toll-like receptors. Japanese Journal of Infectious Diseases 2001, 54(6):209-219.
18. Bowie A.G., Haga I.R. The role of Toll-like receptors in the host response to viruses. Molecular Immunology 2005, 42(8):859-867.
19. Nishijima M., Kawasaki K., Akashi S., Shimazu R., Yoshida T., Miyake K. Mouse toll-like receptor 4 center dot MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by taxol. Journal of Biological Chemistry 2000, 275(4):2251-2254.
20. Ding A.H., Byrd-Leifer C.A., Block E.F., Takeda K., Akira S. The role of MyD88 and TLR4 in the LPS-mimetic activity of taxol. European Journal of Immunology 2001, 31(8):2448-2457.
21. Xiao C.W., Rajput Z.I., Hu S.H. Improvement of a commercial foot-and-mouth disease vaccine by supplement of Quil A. Vaccine 2007, 25(25):4795-4800.
22. Sun H.X., Wang H., Xu H.S., Ni Y. Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity. Vaccine 2009, 27(30):3984-3991.
23. Yuan L., Wu L.H., Chen J., Wu Q., Hu S.H. Paclitaxel acts as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice. Vaccine 2010, 28(27):4402-4410.
24. Bustin S.A. Absolute quantifi{ligature}cation of mRNA using real-time reverse transcription polymerase chain reaction assays. Journal of Molecular Endocrinology 2000, 25:169-193.
25. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[delta][delta]CT method. Methods 2001, 25(4):402-408.
26. Purcell M.K., Kurath G., Garver K.A., Herwig R.P., Winton J.R. Quantitative expression profiling of immune response genes in rainbow trout following infectious haematopoietic necrosis virus (IHNV) infection or DNA vaccination. Fish & Shellfish Immunology 2004, 17(5):447-462.
27. Fitzgerald K.A., Rowe D.C., Barnes B.J., Caffrey D.R., Visintin A., Latz E., et al. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. Journal of Experimental Medicine 2003, 198(7):1043-1055.
28. Sun J.H., Hu S.H., Song X.M. Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice. Vaccine 2007, 25(6):1114-1120.
29. 2) by ginsenoside Re. International Immunopharmacology 2009, 10(3):351-356.
30. Sun J.H., Song X.M., Hu S.H. Ginsenoside Rg1 and aluminum hydroxide synergistically promote immune responses to ovalbumin in BALB/c mice. Clinical and Vaccine Immunology 2008, 15(2):303-307.
31. Madden K.S., Moynihan J.A., Brenner G.J., Felten S.Y., Felten D.L., Livnat S. Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. Journal of Neuroimmunology 1994, 49(1-2):77-87.
32. Bremner P., Heinrich M. Natural products as targeted modulators of the nuclear factor-kappaB pathway. Journal of Pharmacy and Pharmacology 2002, 54(4):453-472.
33. Covert M.W., Leung T.H., Gaston J.E., Baltimore D. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 2005, 309(5742):1854-1857.
34. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. Journal of Immunology 1999, 162(7):3749-3752.
35. Song X.M., Hu S.H. Adjuvant activities of saponins from traditional Chinese medicinal herbs. Vaccine 2009, 27(36):4883-4890.
36. Vermeulen L., De Wilde G., Notebaert S., Vanden Berghe W., Haegeman G. Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochemical Pharmacology 2002, 64(5-6):963-970.